dalteparin has been researched along with Ankylosing Spondylarthritis in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 61-year old patient with ankylosing spondylitis who was on secukinumab therapy for 5 months admitted with newly onset fever and gastrointestinal complaints." | 2.66 | Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review. ( Coskun Benlidayi, I; Guzel, R; Kurtaran, B; Tirasci, E, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coskun Benlidayi, I | 1 |
| Kurtaran, B | 1 |
| Tirasci, E | 1 |
| Guzel, R | 1 |
| Bodur, H | 1 |
| Eser, F | 1 |
| Konca, S | 1 |
| Arikan, S | 1 |
1 review available for dalteparin and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antirheumatic Agents; Betacoronavirus; Coronaviru | 2020 |
1 other study available for dalteparin and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Anticoagulants; Antirheumatic Agents; Enoxaparin; | 2009 |